ARTICLE IN ACADEMIC JOURNALS
NO | DETAILS OF ARTICLE IN ACADEMIC JOURNALS |
---|---|
1. |
Genetic study of early-onset Parkinson's disease in the Malaysian population
2023
Source : PARKINSONISM & RELATED DISORDERS DOI : 10.1016/j.parkreldis.2023.105399 |
2. |
New insights from a multi-ethnic Asian progressive supranuclear palsy cohort
2023
Source : PARKINSONISM & RELATED DISORDERS DOI : 10.1016/j.parkreldis.2023.105296 |
3. |
Genetics Matters: Voyaging from the Past into the Future of Humanity and Sustainability
2022
Source : INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES DOI : 10.3390/ijms23073976 |
4. |
Facile synthesis of biocompatible sub-5 nm alginate-stabilised gold nanoparticles with sonosensitising properties
2021
Author(s) : Chung Lip Yong,Kiew Lik Voon,Zamri Bin Chik,Teo Yin Yin,Lit Lei Cheng,Leo Bey Fen,Foo Yiing Yee,Muhammad Farid Nazer Bin Muhammad Faruqu Source : COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS DOI : 10.1016/j.colsurfa.2021.127141 |
5. |
KSR1 regulates BRCA1 degradation and inhibits breast cancer growth (vol 31, pg 2103, 2015)
2021
Author(s) : Lit Lei Cheng Source : ONCOGENE DOI : 10.1038/s41388-021-01759-9 |
6. |
Clinical phenotype of Parkinson's disease with a homozygous PRKN p.Cys441Arg mutation
2021
Source : NEUROLOGY ASIA |
7. |
LMTK-3 confers chemo-resistance in breast cancer.
2018
Author(s) : Cheah Swee Hung,April Camilla Roslani,Lit Lei Cheng,Justin Stebbing,Kalpit Shah,Teresa Gagliano,Angeliki Ditsiou,Tingting Wang,Franz Wendler,Thomas Simon,Krisztina Szabo,Timothy O'hanlon,Michael Dean Source : Oncogene DOI : 10.1038/s41388-018-0197-0 |
8. |
KSR1 regulates BRCA1 degradation and inhibits breast cancer growth
2015
Author(s) : Lit Lei Cheng Source : Oncogene |
9. |
The kinase LMTK3 promotes invasion in breast cancer through GRB2-mediated induction of integrin
2014
Author(s) : Lit Lei Cheng Source : Science Signaling |
10. |
The regulatory roles of phosphatases in cancer
2014
Author(s) : Lit Lei Cheng Source : Oncogene |
11. |
LMTK3 is implicated in endocrine resistance via multiple signaling pathways
2013
Author(s) : Lit Lei Cheng Source : Oncogene |
12. |
LATS2 is a modulator of estrogen receptor alpha
2013
Author(s) : Lit Lei Cheng Source : Anticancer Research |
13. |
SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1
2013
Author(s) : Lit Lei Cheng Source : British Journal of Cancer |
PROCEEDING
NO | DETAILS OF PROCEEDING |
---|---|
1. |
The role of LMTK3 in breast cancer cell growth and invasion
2013
Author(s) : Lit Lei Cheng |
2. |
Aqueous extract of Rodgersia sambucifolia suppress on the natural killer cell activity in normal subjects and recurrent spontaneous aborters
2010
Author(s) : Lit Lei Cheng |
3. |
Workshop on Isolated Tissue Preparations and HPLC
2007
Author(s) : Lit Lei Cheng |
RESEARCH PROJECT
GRANT | PROGRESS | STATUS |
---|---|---|
Investigating Mitochondrial Dysfunction As A Mechanism Of Fat Loss In Parkinson?s Disease
Researcher(s) : Associate Prof. Dr. Tan Ai Huey,Dr. Ahmad Suhail Bin Khazali,Prof. Dr. Lim Shen-yang
(Private Funding) |
|
end |
Understanding The Mechanism Of Extracellular Release Of ?-synuclein Through Leucine-rich Repeat Kinase 2 (lrrk2) Mutations And Kinase Inhibition
Researcher(s) : Prof. Dr. Lim Shen-yang,Dr. Chee Chin Fei,Associate Prof. Dr. Tan Ai Huey,Dr. Chin Sek Peng
(Fundamental Research Grant Scheme (FRGS)) |
|
end |
RESEARCH COLLABORATOR
GRANT | PROGRESS | STATUS |
---|---|---|
Identifying Leucocyte And Urine Biomarkers In Pd Patients With Lrrk2 G2385r Variant
Researcher(s) : Dr. Lit Lei Cheng,Prof. Dr. Lim Shen-yang,Associate Prof. Dr. Azlina Binti Ahmad Annuar
(International Funding) |
|
on going |
Development Of Ultrasound-responsive-biostealth-nano-pouch For Effective Delivery And Controlled-release Of Tumour Penetrating Metallic Nanoparticles
Researcher(s) : Prof. Dr. Chung Lip Yong,Prof. Dr. Misni Bin Misran,Dr. Leo Bey Fen,Associate Prof. Dr. Teo Yin Yin,Dr. Lit Lei Cheng,Dr. Foo Yiing Yee,Chia-ching Chang,Zhan Yuin Ong
(RU Geran) |
|
end |
Development Of Highly Potent, Selective, And Brain-penetrant Aminopyridoxamine Leucine-rich Repeat Kinase 2 (lrrk2) Inhibitors For Parkinson S Disease Treatment
(Geran Penyelidikan Universiti Malaya (UMRG) - AFR (Frontier Science)) |
|
end |